[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biohaven Ltd (BHVN)

Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,335,201
  • Shares Outstanding, K 150,561
  • Annual Sales, $ 0 K
  • Annual Income, $ -738,820 K
  • EBIT $ -654 M
  • EBITDA $ -644 M
  • 60-Month Beta 1.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.27

Options Overview Details

View History
  • Implied Volatility 87.39% (+0.10%)
  • Historical Volatility 78.23%
  • IV Percentile 6%
  • IV Rank 4.64%
  • IV High 384.04% on 11/04/25
  • IV Low 72.95% on 12/31/25
  • Expected Move (DTE 30) 1.23 (8.29%)
  • Put/Call Vol Ratio 2.33
  • Today's Volume 356
  • Volume Avg (30-Day) 3,766
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 48,467
  • Open Int (30-Day) 63,809
  • Expected Range 13.63 to 16.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.77
  • Number of Estimates 8
  • High Estimate $-0.65
  • Low Estimate $-0.89
  • Prior Year $-1.94
  • Growth Rate Est. (year over year) +60.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.62 +9.36%
on 07/17/26
17.28 -13.80%
on 07/09/26
-0.60 (-3.90%)
since 06/22/26
3-Month
8.22 +81.20%
on 05/19/26
17.28 -13.80%
on 07/09/26
+4.22 (+39.47%)
since 04/22/26
52-Week
7.48 +99.13%
on 11/11/25
18.57 -19.77%
on 10/30/25
+1.47 (+10.91%)
since 07/22/25

Most Recent Stories

More News
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload

Biohaven also announces new clinical supply agreement with Regeneron to evaluate BHV-1530 in combination with cemiplimab (Libtayo®)

BHVN : 14.82 (-4.45%)
Biohaven Announces Scientific Leadership Transitions

NEW HAVEN, Conn. , July 9, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven" or the "Company") today announced scientific leadership role transitions designed to accelerate drug innovation...

BHVN : 14.82 (-4.45%)
Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator

NEW HAVEN, Conn. , June 30, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing...

BHVN : 14.82 (-4.45%)
Stock Indexes Finish Sharply Higher as Tech Soars

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.25%. September E-mini...

GOOGL : 345.51 (-0.47%)
AVGO : 397.54 (+2.86%)
VZ : 44.19 (+0.94%)
AXON : 493.21 (-3.51%)
$IUXX : 29,084.00 (-0.24%)
ASML : 1,804.56 (+0.17%)
MLM : 550.41 (+0.56%)
ZNU26 : 108-140 (-0.19%)
IRDM : 46.89 (-0.74%)
ESU26 : 7,545.25 (-0.01%)
T : 22.78 (+2.34%)
STX : 911.97 (+2.26%)
Stock Indexes Push Higher as Megacap Tech Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) is up +0.73% today; the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. September E-mini S&P futures...

GOOGL : 345.51 (-0.47%)
AAPL : 324.30 (-1.05%)
SNDK : 1,611.80 (+1.41%)
MLM : 550.41 (+0.56%)
TSLA : 374.67 (-1.12%)
AMD : 556.88 (+2.29%)
RBLX : 50.06 (-4.65%)
DOCS : 20.45 (-3.13%)
SPY : 748.13 (-0.02%)
META : 626.40 (-2.70%)
ADSK : 203.20 (-3.77%)
MU : 970.16 (-0.07%)
Stock Indexes Supported by Strength in Megacap Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.59%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.67%. September E-mini S&P futures...

GOOGL : 345.51 (-0.47%)
AAPL : 324.30 (-1.05%)
INTU : 285.94 (-1.37%)
SNDK : 1,611.80 (+1.41%)
DDOG : 246.23 (-3.36%)
AXON : 493.21 (-3.51%)
TXN : 294.38 (+1.06%)
$IUXX : 29,084.00 (-0.24%)
MLM : 550.41 (+0.56%)
ZNU26 : 108-140 (-0.19%)
MSFT : 389.52 (-2.07%)
IRDM : 46.89 (-0.74%)
Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease

NEW HAVEN, Conn. , June 29, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) today announced enrollment of the first patient in the pivotal Phase 3 trial of BHV-1300 for Graves' disease. BHV-1300...

BHVN : 14.82 (-4.45%)
Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation

NEW HAVEN, Conn. , June 1, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization...

BHVN : 14.82 (-4.45%)
Biohaven Reports Positive Clinical Biomarker and Patient Data: First MoDE and TRAP Extracellular Protein Degraders Achieve Deep, Rapid, Selective Lowering of Disease-Driving Antibodies in Graves' Disease and IgA Nephropathy

NEW HAVEN, Conn. , May 27, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven") a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization...

BHVN : 14.82 (-4.45%)
Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile

NEW HAVEN, Conn. , May 26, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing...

BHVN : 14.82 (-4.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut....

See More

Key Turning Points

3rd Resistance Point 16.48
2nd Resistance Point 16.03
1st Resistance Point 15.77
Last Price 14.82
1st Support Level 15.05
2nd Support Level 14.60
3rd Support Level 14.34

See More

52-Week High 18.57
Last Price 14.82
Fibonacci 61.8% 14.33
Fibonacci 50% 13.02
Fibonacci 38.2% 11.71
52-Week Low 7.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.